Sometimes a tumor suddenly starts growing rapidly or becomes resistant to cancerdrugs. This can be caused by a cancer gene “striking out on its own” in ring shapes. ECRC-scientist Anton Henssen described how these DNA rings arise and continue to…
"Basic research is the basis for innovation"
New Professor of Experimental Rheumatology and Scientific Director of the DRFZ
The Charité – Universitätsmedizin Berlin appointed Prof. Dr. Eicke Latz as Professor of Experimental Rheumatology on 1 May. He simultaneously became the new Scientific…
A proteome is the entirety of all active protein molecules present within an organism, a certain type of tissue, or a cell under specific conditions and at a certain time. Now, an international team of researchers led by members from Charité –…
Berlin, April 24, 2023 – 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications, today announced that it has entered into an amended and restated…
Berlin, 20 April 2023 - Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), has received the manufacturing authorization for Lutetium-177 (non-carrier-added Lu-177) in GMP…
Global Leader in Cardiac Rhythm Technology Solutions Expands Therapies for the Treatment of Chronic Intractable Pain with a New Approach to Managing Spinal Cord Stimulation
Berlin/Singapore (April 14, 2023)
Berlin, Germany and Zurich, Switzerland – April 12, 2023
New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million
Funds will be used to advance clinical pipeline and further build Ariceum Therapeutics
Olivier Litzka…
